These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29427202)

  • 1. Predictors of vasomotor symptoms among breast cancer survivors.
    Reeves KW; Pennell M; Foraker RE; Crandall CJ; Stefanick M; Paskett ED
    J Cancer Surviv; 2018 Jun; 12(3):379-387. PubMed ID: 29427202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasomotor Symptoms and Accelerated Epigenetic Aging in the Women's Health Initiative (WHI).
    Thurston RC; Carroll JE; Levine M; Chang Y; Crandall C; Manson JE; Pal L; Hou L; Shadyab AH; Horvath S
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1221-7. PubMed ID: 32080740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasomotor symptoms in midlife women with incident breast cancer: pink SWAN.
    Gold EB; Crawford SL; Leung K; Greendale G; Reeves KW; Joffe H; Avis NE
    Breast Cancer Res Treat; 2022 Jan; 191(1):125-135. PubMed ID: 34694536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasomotor menopausal symptoms are not associated with incidence of breast cancer in a population-based cohort of mid-aged women.
    Johanneke van den Berg M; Mishra GD; van der Schouw YT; Herber-Gast GC
    Eur J Cancer; 2014 Mar; 50(4):824-30. PubMed ID: 24361228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of women's treatment preferences for vasomotor symptoms due to menopause.
    Shiozawa A; Thurston RC; Cook E; Yang H; King DD; Kristy RM; Mancuso S
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(10):1117-1128. PubMed ID: 37650213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasomotor symptom characteristics: are they risk factors for incident diabetes?
    Gray KE; Katon JG; LeBlanc ES; Woods NF; Bastian LA; Reiber GE; Weitlauf JC; Nelson KM; LaCroix AZ
    Menopause; 2018 May; 25(5):520-530. PubMed ID: 29206771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of the Vasomotor Symptoms of Menopause: Twofers in Your Clinical Toolbox.
    Kling JM; Stuenkel CA; Faubion SS
    Mayo Clin Proc; 2024 Jul; 99(7):1142-1148. PubMed ID: 38960498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women's Health Across the Nation.
    Hart V; Sturgeon SR; Reich N; Sievert LL; Crawford SL; Gold EB; Avis NE; Reeves KW
    Cancer Causes Control; 2016 Nov; 27(11):1333-1340. PubMed ID: 27680016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep difficulty mediates effects of vasomotor symptoms on mood in younger breast cancer survivors.
    Vincent AJ; Ranasinha S; Sayakhot P; Mansfield D; Teede HJ
    Climacteric; 2014 Oct; 17(5):598-604. PubMed ID: 24673553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasomotor symptoms and coronary artery calcium in postmenopausal women.
    Allison MA; Manson JE; Aragaki A; Langer RD; Rossouw J; Curb D; Martin LW; Phillips L; Stefanick ML; Cochrane BB; Sarto G; Barnhart J; O'Sullivan MJ; Johnson KC; Gass M; Trevisan M; Woods NF
    Menopause; 2010; 17(6):1136-45. PubMed ID: 20651617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lifetime lactation on the risk and duration of frequent vasomotor symptoms: A longitudinal dose-response analysis.
    Scime NV; Shea AK; Faris PD; Brennand EA
    BJOG; 2023 Jan; 130(1):89-98. PubMed ID: 35993429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis.
    Davis SR; Panjari M; Robinson PJ; Fradkin P; Bell RJ
    Menopause; 2014 Oct; 21(10):1075-81. PubMed ID: 24618765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasomotor symptoms and cardiovascular disease risk.
    Pines A
    Climacteric; 2011 Oct; 14(5):535-6. PubMed ID: 21848496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasomotor Symptoms and Quality of Life Among Veteran and Non-Veteran Postmenopausal Women.
    Katon JG; Gray KE; Gerber MR; Harrington LB; Woods NF; Weitlauf JC; Bean-Mayberry B; Goldstein KM; Hunt JR; Katon WJ; Haskell SG; McCutcheon SJ; Gass ML; Gibson CJ; Zephyrin LC
    Gerontologist; 2016 Feb; 56 Suppl 1():S40-53. PubMed ID: 26220418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hot Flash Frequency and Blood Pressure: Data from the Study of Women's Health Across the Nation.
    Jackson EA; El Khoudary SR; Crawford SL; Matthews K; Joffe H; Chae C; Thurston RC
    J Womens Health (Larchmt); 2016 Dec; 25(12):1204-1209. PubMed ID: 27404767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms.
    Umland EM
    J Manag Care Pharm; 2008 Apr; 14(3 Suppl):14-9. PubMed ID: 18439062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is an unfavourable cardiovascular risk profile a risk factor for vasomotor menopausal symptoms? Results of a population-based cohort study.
    van den Berg MJ; Herber-Gast GC; van der Schouw YT
    BJOG; 2015 Aug; 122(9):1252-8. PubMed ID: 25515605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years.
    Gartoulla P; Worsley R; Bell RJ; Davis SR
    Menopause; 2018 Nov; 25(11):1331-1338. PubMed ID: 30358730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of menopausal vasomotor symptoms with fracture incidence.
    Crandall CJ; Aragaki A; Cauley JA; Manson JE; LeBlanc E; Wallace R; Wactawski-Wende J; LaCroix A; O'Sullivan MJ; Vitolins M; Watts NB
    J Clin Endocrinol Metab; 2015 Feb; 100(2):524-34. PubMed ID: 25522264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.